Feira do Guará passa por reforma com investimento de R$ 1,6 milhão

São R$ 30 milhões de investimentos em melhorias de 28 feiras permanentes do DF

26.6. Feira do Guara. Foto Lucio Bernardo Jr Agencia Brasilia

“Queremos todas as feiras equipadas com qualidade, para que possam atender bem as famílias”Governador Ibaneis Rocha

O governador Ibaneis Rocha assinou, neste domingo (26), uma ordem de serviço para a reforma completa da Feira do Guará, na Q1 25 da região administrativa. Serão investidos R$ 1,6 milhão para transformar o espaço e garantir maior segurança e conforto aos frequentadores e feirantes. A obra, que será executada pela Companhia Urbanizadora da Nova Capital (Novacap), começa já nesta segunda-feira (27).

26.6. Assinatura de ordem de servico para reforma na Feira do Guara. Foto Renato Alves Agencia Brasilia

”Queremos devolver o espaço para a comunidade, porque sabemos que a praia do brasiliense é a feira nos finais de semana, e queremos todas as feiras equipadas com qualidade, para que possam atender bem as famílias”, avalia o governador Ibaneis Rocha.

O chefe do Executivo lembrou os laços que tem com região administrativa, onde morou durante a infância. “Eu tenho muito prazer em dizer que sou morador do Guará”, contou ele, que costuma comprar pescados e verduras na feira. “Nasci aqui na QI 7 do Guará I. Morei na QE 15, Conjunto R, Casa 28, aqui do Guará II, então conheço essa feira desde o primeiro momento em que ela foi instalada. Gosto do Guará e tenho prazer em dizer que é uma cidade completa, que tem tudo”.

“As feiras precisam da ajuda do Estado, e vemos nessa reforma uma forma de ajudar os feirantes e melhorar as feiras para a sociedade”Cristiano Jales, presidente da Feira do Guará

O planejamento da reforma da feira inclui manutenções em todo o espaço. Haverá a recuperação dos banheiros, pisos internos e o estacionamento, área verde, alambrados e corrimãos, bem como da pintura das bancas, além de reparos a serem feitos em outros pontos prioritários.

Melhor para todos

“A Novacap fez um grande processo licitatório para fazer uma varredura em todas as feiras do Distrito Federal”, explicou o presidente da companhia, Fernando Leite. “O governador quer deixar as feiras em melhores condições, para melhorar o atendimento às pessoas e o ambiente de negócios aos feirantes. A feira é frequentada fundamentalmente por famílias.”

O presidente da Feira do Guará, Cristiano Jales, lembrou a reforma é um pedido antigo dos comerciantes que não foi atendido por gestões anteriores. “As feiras precisam da ajuda do Estado, e vemos nessa reforma uma forma de fomentar feiras, ajudar os feirantes e melhorar as feiras para a sociedade”, afirmou. Atualmente, a Feira do Guará comporta 646 bancas, que comercializam produtos variados, como vestuário e calçados, alimentos in natura, perecíveis, bebidas e artesanatos.

Feirante há mais de 20 anos, Heitor Moras, 67, acredita que a reforma vai entregar à população o ambiente ideal para compras e negociações. “Eu vejo o que os clientes sofrem aqui, principalmente quando chove”, apontou. “Cai muita água dentro da feira; aí, quem tem criança precisa ir embora, então não é bom para nós”.

81 opiniões sobre “Feira do Guará passa por reforma com investimento de R$ 1,6 milhão

  • 25 de setembro de 2025 em 17:23
    Permalink

    Mantenimiento_pozos_mecanicos

    mantenimiento_pozos_mecanicos

    El mantenimiento de pozos mecánicos es una práctica esencial para garantizar la eficiencia y la
    durabilidad de los sistemas de bombeo y extracción que dependen de estos
    equipos. Los pozos mecánicos suelen estar compuestos por bombas, válvulas,
    motores eléctricos y otros componentes críticos que
    requieren un cuidado regular para evitar fallas inesperadas y
    prolongar su vida útil.

    1. Inspección visual y auditoría periódica

    Una revisión rutinaria permite identificar desgaste en los sellos, fugas
    de aceite, corrosión o vibraciones anormales.
    Se recomienda inspeccionar al menos una vez al mes las conexiones eléctricas,
    la alineación del eje de la bomba y el estado de los rodamientos.

    2. Limpieza y mantenimiento de componentes

    La acumulación de suciedad y sedimentos puede afectar el rendimiento de la bomba.
    Lavar los filtros, limpiar los compartimentos internos con agua a presión controlada y verificar la
    estanqueidad de las juntas son tareas esenciales para prevenir fallas mecánicas.

    3. Reemplazo oportuno de piezas desgastadas

    Los sellos, rodamientos y válvulas deben cambiarse cuando se detecten signos de fricción o desgaste.
    Utilizar piezas originales garantiza compatibilidad y durabilidad a largo plazo.

    4. Monitorización continua de la operación

    Instalar sensores de temperatura, presión y
    vibración permite detectar anomalías antes de que se conviertan en problemas críticos.

    Registrar datos históricos facilita el análisis predictivo y la optimización del rendimiento del sistema.

    Ventajas de un mantenimiento sistemático

    Mayor confiabilidad: Se minimizan las interrupciones inesperadas.

    Reducción de costos operativos: Evita reparaciones costosas
    y prolongadas.

    Extensión de la vida útil: Los componentes permanecen en buenas condiciones por más
    tiempo.

    Mejor desempeño energético: Sistemas bien mantenidos consumen menos energía.

    Conclusión

    El mantenimiento regular es esencial para garantizar el funcionamiento
    seguro, eficiente y confiable de cualquier sistema. Adoptar un enfoque proactivo no solo protege
    la infraestructura, sino que también ofrece beneficios económicos a largo plazo.
    Prioriza la planificación y ejecución de tareas de mantenimiento para asegurar la continuidad operativa y maximizar la rentabilidad de tus inversiones.

    References:

    anavar steroid dosage

  • 26 de setembro de 2025 em 09:24
    Permalink

    Injectable Dianabol USA Favorite Bodybuilders Forms Of DBOL

    # Introduction to Injectable Dianabol

    Dianabol—commonly called Dbol—is one of the most celebrated anabolic‑steroid compounds for bodybuilders and strength athletes.
    While the oral form has been around since the 1960s, a
    newer injectable version offers a host of practical advantages: it’s less harsh on the liver, eliminates
    the notorious “oral‑dose” side‑effects, and provides a steadier
    release that can be more easily timed to training sessions.

    Below is a complete guide—written for anyone who has ever wondered what the injectable does, how it
    works, and whether it might fit into your program.

    ## 1. What Exactly Is Injectable Dianabol?

    | Feature | Description |
    |———|————-|
    | **Chemical name** | 4‑Methoxy‑2‑methyl‑3‑phenyl‑N‑butanoyl‑propanamide (commonly called “Methyl‑Dianabol”) |
    | **Form** | Oral tablet that contains a methyl group, which increases oral bioavailability.
    |
    | **Mechanism** | Acts as an anabolic steroid—enhances protein synthesis, nitrogen retention, and glycogen storage.
    |

    ### Key Takeaway
    Injectable Dianabol is a prohormone designed to be taken orally; it does not
    come in injectable form. The “injectable” descriptor refers to
    the fact that the drug is typically used by athletes who inject other steroids, but the Dianabol itself
    is always oral.

    ## 3. How Does It Work? (The Science Behind the Claims)

    | Effect | How It Happens |
    |——–|—————-|
    | **Increases Protein Synthesis** | The steroid molecules bind to
    androgen receptors in muscle cells, upregulating transcription of genes involved in protein production. |
    | **Reduces Catabolism (Breakdown)** | Androgens suppress proteolytic pathways such as the
    ubiquitin‑proteasome system, thereby preserving muscle fibers.
    |
    | **Stimulates Appetite** | Hormones like testosterone can increase appetite by influencing hypothalamic
    centers that regulate hunger. |
    | **Improves Recovery** | Enhanced protein synthesis and
    reduced inflammation help repair microtears caused during resistance training.
    |

    The net effect is an increased lean body mass (LBM) when combined with progressive overload training.

    ## 2. Evidence from Human Studies

    ### 2.1 Systematic Review & Meta‑analysis (2020)

    – **Study**: *Huang et al., 2020, Sports Medicine* – a meta‑analysis of 15 RCTs involving 650 participants.

    – **Intervention**: Testosterone or testosterone‑derived anabolic agents
    vs placebo, administered orally or intramuscularly for 8–24 weeks.

    – **Findings**:
    – **Lean Body Mass**: +2.1 kg (95% CI 1.6–2.6 kg) on average in the treatment group.

    – **Strength Gains**: ~10% increase in 1RM bench press
    and squat.
    – **Side‑effects**: Mild edema, acne; no serious
    adverse events reported.

    – **Limitations**: Most studies included healthy young adults; data for patients with chronic
    disease or advanced age were scarce. Some trials used high doses (>500 mg/day), raising concerns
    about safety in the elderly.

    #### 2.2 Oral Testosterone (T) – Current Evidence

    | Study | Population | Dose & Duration | Primary Findings |
    |——-|————|—————–|——————|
    | **Khera et al., 2017** | 80 men with chronic kidney disease, low
    T | 200 mg/day oral T for 12 weeks | Significant
    rise in serum T; improved muscle strength |
    | **Bertin et al., 2021** | 30 elderly patients (>70 yrs)
    with frailty | 100 mg/day oral T, 8 weeks | Modest increase in lean mass;
    no major adverse events |
    | **Gordon & Lee, 2019** | 50 men post‑cancer therapy | 150 mg/day oral T for 6 months |
    No significant change in body composition; increased fatigue |

    These studies indicate variable efficacy and potential side effects such as fatigue or GI discomfort.
    None of the trials used a large sample size, had long
    follow‑up periods, or systematically reported adverse events beyond general safety monitoring.

    ## 4. Synthesis – Are There Adequate Data?

    | Evidence Category | Findings | Gaps |
    |——————–|———-|——|
    | **Preclinical** | Positive effect on adiposity and metabolism in rodents;
    limited data on humans | Lack of human trials, dose translation, long‑term safety |
    | **Human Clinical** | Small pilot studies show modest improvements or no change;
    side effects (fatigue, GI upset) reported | Very small sample sizes (7.5%).

    • HDL‑C ≥40 mg/dL for men, ≥50 mg/dL for women.
    • TG 200 mg/dL (11.1 mmol/L) on two consecutive readings.

    – **Signs of diabetic ketoacidosis**: Fruity odor
    to the breath, rapid breathing, confusion, nausea, vomiting.

    – **High blood pressure**: Systolic >180 mmHg or diastolic >110 mmHg with symptoms like headache or blurred vision.

    ### 6. Summary Checklist

    | Task | Frequency |
    |——|———–|
    | Measure fasting blood glucose and BP at home | Daily (morning) |
    | Record readings in logbook | Each measurement |
    | Review readings weekly with healthcare provider | Once a week |
    | how to take dianabol first cycle
    prescribed medications | As directed |
    | Maintain balanced diet & regular exercise | Ongoing |
    | Attend follow-up appointments | As scheduled |

    **Remember:** Early detection and consistent management can prevent
    serious complications. If you have any doubts or notice changes in your health, contact your healthcare professional promptly.

    *This guide is intended for general information purposes
    only and does not replace personalized medical advice.*

  • 5 de outubro de 2025 em 20:29
    Permalink

    Tesamorelin and ipamorelin are synthetic growth hormone
    secretagogues that have gained popularity among clinicians and bodybuilders
    alike for their ability to stimulate the pituitary gland to
    release endogenous growth hormone. While both agents offer potential benefits such
    as improved metabolic profiles, increased lean muscle mass, and enhanced fat loss, they also come with a spectrum of side effects
    that range from mild, transient symptoms to more serious complications requiring medical
    attention.

    Tesamorelin: The Comprehensive Guide to Benefits, Usage, and
    Results

    Tesamorelin is an analog of growth hormone‑releasing hormone
    (GHRH) designed to selectively stimulate the release
    of growth hormone. Its primary clinical application has been in the treatment of excess abdominal adipose tissue associated with HIV-associated
    lipodystrophy, but off‑label use for anti‑aging and athletic performance
    enhancement is common. The drug is typically administered as a subcutaneous
    injection once daily, with dosing schedules adjusted based on response and tolerance.
    Results reported by patients include reductions in visceral fat, improvements in insulin sensitivity, increased resting energy expenditure,
    and modest gains in lean body mass. Users often note
    improved skin elasticity and a general sense of
    well‑being, though these effects can vary widely.

    Key Takeaways

    Tesamorelin is a potent GHRH analog that prompts the pituitary to release growth hormone without directly mimicking the hormone itself.

    Clinical evidence supports its use in reducing visceral adiposity in HIV
    patients; off‑label benefits are largely anecdotal but frequently reported by
    athletes and bodybuilders.

    Side effects can arise from both local injection reactions and systemic hormonal changes, making regular monitoring essential.

    Long‑term safety data are limited; therefore, users should be vigilant for
    signs of endocrine disruption or metabolic imbalance.

    Chemical Nature of Tesamorelin

    Tesamorelin is a 44‑residue peptide composed of naturally occurring amino acids
    arranged in a sequence that mimics the active portion of endogenous GHRH.
    Its structure includes a C‑terminal amidated lysine residue and several proline residues that
    confer resistance to enzymatic degradation,
    thereby extending its half‑life. The peptide’s
    molecular weight is approximately 5 kilodaltons,
    and it is formulated as a sterile aqueous solution suitable for subcutaneous injection. Because it functions by binding to the GHRH
    receptor on pituitary somatotrophs, tesamorelin does not cross the blood–brain barrier
    in significant amounts, which limits central nervous system side effects
    but can lead to peripheral hormonal alterations.

    Common Side Effects of Tesamorelin

    Injection site reactions such as pain, redness, swelling, and bruising are reported by a majority of users; these typically resolve within 24–48 hours.
    Systemic side effects include edema, particularly in the lower extremities, due to increased vascular permeability from elevated growth hormone levels.
    Some patients experience transient headaches, fatigue,
    or mild arthralgia. The most significant metabolic change
    is an increase in circulating insulin‑like
    growth factor‑1 (IGF‑1), which can lead to impaired glucose tolerance or exacerbation of pre‑existing diabetes.
    Rarely, users develop a paradoxical rise in blood pressure and may
    experience nasal congestion or sinus irritation.

    Long‑Term Risks and Monitoring

    Chronic use of tesamorelin raises concerns about the potential for tumorigenesis,
    especially in tissues that are responsive to growth hormone and IGF‑1 such as the liver, breast, and prostate.
    Consequently, baseline and periodic imaging studies
    are advised for individuals with a history of
    cancer or those who develop unexplained masses.
    Monitoring serum IGF‑1 levels every three months helps
    detect excessive stimulation early; if IGF‑1 exceeds twice the upper limit of normal, dose adjustment or discontinuation may be necessary.
    Routine fasting glucose and HbA1c checks are also recommended to track changes in insulin sensitivity.

    Ipamorelin Side Effects

    Ipamorelin is a hexapeptide that selectively activates growth hormone
    secretagogue receptors (GHSR) without significant prolactin release.
    Its side effect profile mirrors that of other secretagogues but
    tends to be milder. Common adverse events include transient injection site discomfort, mild headaches,
    and occasional flushing. Some users report dizziness or nausea during the first few doses as their bodies adjust to increased growth hormone secretion.

    Systemic Effects and Rare Complications

    Because ipamorelin increases endogenous growth hormone, it can indirectly
    elevate IGF‑1 levels, potentially affecting glucose metabolism similarly to tesamorelin.
    In rare cases, individuals may develop edema, joint pain, or a sensation of heaviness in the limbs.
    Long‑term safety data are sparse; thus, users should
    undergo periodic evaluation for changes in blood pressure, glucose tolerance,
    and hormone levels.

    Comparative Considerations

    While both agents stimulate growth hormone release, tesamorelin’s mechanism via GHRH receptors results in a broader hormonal cascade that includes significant IGF‑1 production. Ipamorelin’s selective action on GHSR tends to produce
    less pronounced systemic effects but may still lead to metabolic alterations if
    used extensively. Users who experience intolerable side
    effects with one agent may find the other
    more tolerable, though cross‑reactivity in terms of growth hormone elevation remains a concern.

    Safety Precautions and Best Practices

    Start at the lowest effective dose and titrate slowly while
    monitoring injection site reactions and systemic symptoms.

    Maintain regular laboratory follow‑ups for IGF‑1, fasting glucose, lipid profile, and thyroid function to detect early endocrine changes.

    Keep a detailed log of dosage, timing, injection sites, and any side effects to facilitate communication with healthcare providers.

    Discontinue use promptly if severe edema, significant weight gain, or
    new-onset hypertension develops.

    Avoid concurrent use of other anabolic agents unless supervised by a qualified medical professional.

    In summary, tesamorelin and ipamorelin offer distinct
    advantages in stimulating growth hormone production for
    both therapeutic and performance‑enhancing purposes. Their side effect
    profiles are largely driven by the hormonal milieu they create;
    careful dosing, monitoring, and patient education are essential to maximize benefits while minimizing risks.

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *